Profile data is unavailable for this security.
About the company
Fuji Pharma Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of medical products. The Company is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. The Company's products are primarily used to treat dysmenorrhea, endometriosis, pregnancy and childbirth, and menopause.
- Revenue in JPY (TTM)54.57bn
- Net income in JPY2.33bn
- Incorporated1965
- Employees1.76k
- LocationFuji Pharma Co Ltd6FIzumidate Bujin Tori, 5-7, Sanban-choCHIYODA-KU 102-0075JapanJPN
- Phone+81 335563344
- Fax+81 335564455
- Websitehttps://www.fujipharma.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Seikagaku Corp | 35.86bn | -755.00m | 41.08bn | 1.08k | -- | 0.5407 | 30.82 | 1.15 | -13.84 | -13.84 | 656.96 | 1,337.18 | 0.4328 | 2.03 | 3.92 | 33,360,930.00 | -0.9099 | 3.60 | -0.9881 | 3.96 | 40.92 | 52.56 | -2.10 | 7.94 | 4.26 | -- | 0.0049 | 55.17 | 8.73 | 6.57 | -44.46 | -- | 18.48 | 2.90 |
| Daito Pharmaceutical Co Ltd | 51.20bn | 2.23bn | 42.44bn | 1.07k | 18.95 | 0.7995 | 6.40 | 0.8288 | 74.42 | 74.42 | 1,703.91 | 1,763.62 | 0.6544 | 2.16 | 2.76 | 47,716,680.00 | 2.90 | 5.12 | 3.71 | 6.67 | 17.63 | 21.75 | 4.43 | 7.35 | 1.31 | -- | 0.1739 | 24.48 | 7.99 | 2.39 | -42.09 | -13.52 | 20.45 | 14.00 |
| Fuji Pharma Co Ltd | 54.57bn | 2.33bn | 59.74bn | 1.76k | 25.14 | 1.22 | 9.50 | 1.09 | 95.46 | 95.46 | 2,233.29 | 1,959.48 | 0.5765 | 1.49 | 2.83 | 31,007,950.00 | 2.46 | 4.51 | 3.93 | 6.76 | 40.82 | 40.57 | 4.27 | 8.51 | 0.876 | 17.58 | 0.3885 | 25.98 | 12.01 | 8.87 | -51.19 | 7.55 | 8.07 | 7.94 |
| Oncolys Biopharma Inc | 28.55m | -2.06bn | 64.88bn | 35.00 | -- | 16.21 | -- | 2,272.86 | -80.66 | -80.66 | 1.11 | 136.64 | 0.0074 | 0.00 | 0.1004 | -- | -53.08 | -53.26 | -58.54 | -60.19 | 0.00 | -- | -7,209.58 | -484.93 | 9.54 | -424.60 | 0.0741 | -- | -9.04 | -38.10 | -22.16 | -- | 2.22 | -- |
| Cuorips Inc | 355.69m | -764.60m | 68.79bn | 56.00 | -- | 13.70 | -- | 193.40 | -93.30 | -93.30 | 43.60 | 607.39 | 0.0656 | 3.33 | 238.00 | 6,351,607.00 | -14.20 | -- | -14.62 | -- | 76.69 | -- | -216.57 | -- | 36.81 | -- | 0.00 | -- | 658.40 | -- | -1.92 | -- | -- | -- |
| ASKA Pharmaceutical Holdings Co Ltd | 68.70bn | 4.91bn | 71.53bn | 1.63k | 14.38 | 1.03 | 9.23 | 1.04 | 172.92 | 172.92 | 2,421.07 | 2,420.68 | 0.6729 | 1.37 | 3.62 | 42,094,980.00 | 4.93 | 5.50 | 6.64 | 7.07 | 48.33 | 47.56 | 7.32 | 7.98 | 1.23 | 75.35 | 0.1551 | 16.60 | 2.06 | 4.07 | -32.39 | 51.04 | 9.49 | 31.48 |
| Nxera Pharma Co Ltd | 29.62bn | -12.53bn | 81.18bn | 374.00 | -- | 1.33 | -- | 2.74 | -138.60 | -138.60 | 328.05 | 674.04 | 0.2069 | 0.8144 | 4.11 | -- | -8.75 | -3.79 | -9.90 | -4.16 | 72.32 | 80.12 | -42.31 | -22.17 | 1.90 | -1.30 | 0.4847 | -- | 2.71 | 27.35 | -158.99 | -- | 42.87 | -- |
| JCR Pharmaceuticals Co Ltd | 37.55bn | -2.44bn | 87.93bn | 987.00 | -- | 1.79 | 189.09 | 2.34 | -19.98 | -19.98 | 307.86 | 379.76 | 0.3432 | 0.4534 | 2.50 | 38,039,510.00 | -2.21 | 5.86 | -3.77 | 9.33 | 70.45 | 73.83 | -6.45 | 13.60 | 0.668 | -- | 0.5295 | 45.13 | -22.86 | 5.94 | -186.42 | -- | 15.37 | 20.11 |
Data as of Feb 20 2026. Currency figures normalised to Fuji Pharma Co Ltd's reporting currency: Japanese Yen JPY
13.05%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| SBI Asset Management Co., Ltd.as of 22 Jul 2025 | 712.20k | 2.86% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 511.36k | 2.05% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 481.09k | 1.93% |
| Nomura Asset Management Co., Ltd.as of 06 Feb 2026 | 465.60k | 1.87% |
| Amova Asset Management Co., Ltd.as of 06 Feb 2026 | 230.90k | 0.93% |
| Daiwa Asset Management Co. Ltd.as of 30 Jan 2026 | 206.20k | 0.83% |
| T&D Asset Management Co., Ltd.as of 25 Apr 2025 | 199.60k | 0.80% |
| Carrera Asset Management Co., Ltd.as of 25 Aug 2025 | 175.00k | 0.70% |
| American Century Investment Management, Inc.as of 05 Feb 2026 | 171.00k | 0.69% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Feb 2026 | 95.60k | 0.38% |
More ▼
Data from 22 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
